Berberine‐Pretreated Bone Marrow Mesenchymal Stem Cells Accelerate Skin Wound Healing in Rats With Burn Injuries
International Wound Journal · 2026
DOI: 10.1111/iwj.71029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Wound Journal, 2026. Verfasst von Jinglei Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burn and Wound Repair, Wenling First People's Hospital, Taizhou, China. Hauptthemen laut MEDLINE: Wound Healing, Burns, Berberine, Mesenchymal Stem Cells. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Medical Science and Technology Plan Project.
Themen: Wundversorgung
Abstract (Originalsprache)
Berberine (BBR) is a natural isoquinoline alkaloid with antibacterial, anti‐inflammatory and pro‐angiogenic properties. This study aimed to investigate the therapeutic efficacy and underlying mechanism of a conditioned medium (CM) derived from berberine‐preconditioned bone marrow‐derived mesenchymal stem cells (BMSCs‐BBR). BMSCs were isolated and phenotypically characterised by flow cytometry. A burn wound model was established in Wistar rats, and the model rats were randomly allocated to four groups treated with placebo gel, standard BMSCs‐CM gel, BMSCs‐BBR CM gel, or silver sulfadiazine cream. Wound healing rates were monitored macroscopically. On Day 21, skin tissues were harvested for histological analysis (H&E and Masson's trichrome staining), followed by immunofluorescence staining (CD31) and Western blot analysis (Collagen I, Collagen III and key proteins in the PI3K/AKT/eNOS signalling pathway). Among all treatments, BMSCs‐BBR CM accelerated wound closure the most significantly, accompanied by improved epidermal regeneration, enhanced collagen deposition and organisation and a marked increase in capillary density. Furthermore, wounds treated with BMSCs‐BBR CM exhibited notably upregulated Collagen I and Collagen III, and activation of the PI3K/AKT/eNOS pathway, as evidenced by increased phosphorylation of PI3K and AKT and elevated eNOS protein levels. Our findings demonstrate that the topical application of BMSCs‐BBR CM gel potently promotes burn wound healing by improving the quality of tissue regeneration and stimulating angiogenesis via the activation of the PI3K/AKT/eNOS signalling pathway. This preconditioning strategy represents a promising acellular therapeutic approach for burn wound management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Burn and Wound Repair, Wenling First People's Hospital, Taizhou, China.
ORCID-Profile: Caiqiang Chen
Förderung
- Zhejiang Provincial Medical Science and Technology Plan Project
Zitieren
APA
Tan, J., & Chen, C. (2026). Berberine‐Pretreated Bone Marrow Mesenchymal Stem Cells Accelerate Skin Wound Healing in Rats With Burn Injuries. International Wound Journal. https://doi.org/10.1111/iwj.71029
Vancouver
Tan J, Chen C. Berberine‐Pretreated Bone Marrow Mesenchymal Stem Cells Accelerate Skin Wound Healing in Rats With Burn Injuries. International Wound Journal. 2026. doi:10.1111/iwj.71029
BibTeX
@article{Tan2026,
author = {Tan, Jinglei and Chen, Caiqiang},
title = {Berberine‐Pretreated Bone Marrow Mesenchymal Stem Cells Accelerate Skin Wound Healing in Rats With Burn Injuries},
journal = {International Wound Journal},
year = {2026},
doi = {10.1111/iwj.71029}
}
EUVIMED